semaglutide obesity phase 3 7·2 mg was modestly superior to placebo and 2·4 mg (#wegovy) for #WeightLoss in adults with obesity, while retaining a favourable risk–benefit profile. We recently had the lead author on the Two Years on Semaglutide -

The efficacy and safety of -nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: A randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial

This disease of unknown origin is marked by the triad of polyostotic fibrous dysplasia, precocious puberty, and cutaneous pigmentation

Individuals looking for a non-surgical treatment option that can help them lose weight gradually without extreme calorie restrictions or intense exercise routines

Mindful eating strategies help patients reconnect with internal hunger cues

Comnmente se le conoce como el antioxidante maestro, por su papel crucial en la proteccin celular

For most, combining retatrutide with consistent physical activity has been an incremental journey, with its victories and bruises